Breast Cancer Animations – Breast Cancer Illustrations

Important Information For Patients From Susan G. Komen For The Cure® And The College Of American Pathologists
Recent media reports of potential misdiagnosis of early-stage breast cancer may frighten women away from breast cancer screening that could save their lives. Rather than shying away from screening, women should know the questions to ask and be confident about weighing their options, according to Susan G...

Abraxis BioScience And Specialised Therapeutics Announce Approval To Market ABRAXANE For Metastatic Breast Cancer In New Zealand
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, and Specialised Therapeutics Ltd. today announced that MEDSAFE, the New Zealand Medicines and Medical Devices Safety Authority, has approved for marketing ABRAXANE® (nanoparticle albumin-bound paclitaxel) for the treatment of metastatic breast cancer after failure of anthracycline therapy...

More Funding Needed For Breast, Cervical Cancer Detection Program, Advocates Say
During an event to mark its 20th anniversary, advocates of the National Breast and Cervical Cancer Early Detection Program on Tuesday expressed frustration that the program has not been extended to more low-income women and urged Congress to increase funding, CQ HealthBeat reports...

Breakthrough Breast Cancer Identifies Potential New Treatment Which Could Help 800 Scottish Women Each Year
Scientists from the Breakthrough Breast Cancer Research Unit at the University of Edinburgh have discovered a potential new way to treat a common form of breast cancer which affects 800 Scottish women and 9,000 UK women each year. The team are the first to identify a gene's key role in causing the spread of HER2 positive breast cancer to other parts of the body...

Cytori Gains Stem Cell Device Approval In Europe For Breast Cancer Reconstruction And Soft Tissue Repair
Cytori Therapeutics (NASDAQ: CYTX) received expanded European approval (CE Mark) for its Celution® System, a medical device that extracts and separates stem and regenerative cells from a patient's own fat tissue...

Additional Research Funds To TGen From The Marilyn B. Gula Mountains Of Hope Foundation To Support Advanced Breast Cancer Research And Treatment
The Marilyn B. Gula Mountains of Hope Foundation continues its fight against advanced breast cancer with a $50,000 donation to the Phoenix-based Translational Genomics Research Institute (TGen), for a total contribution over two years of $300,000...

1,500 Canadian Women To Take Part In 5-Year Breast Cancer Survivorship Study
Over the next five years, a diverse, multi-disciplinary team of researchers led by Dr. Kerry Courneya of the University of Alberta and Dr. Christine Friedenreich of Alberta Health Services will conduct a series of five large research projects to probe the impacts of physical activity on breast cancer thanks to a $2...

Women In Their 40s Have Lower Mammographic Tumor Detectability
The reduced effectiveness of mammographic screening in women in their forties is primarily due to lower detectability instead of faster tumor growth rate, according to a study published online July 27 in The Journal of the National Cancer Institute...

New Molecular Marker Could Predict If Breast Cancer Patients Need Chemotherapy
A new predictive marker which could help doctors to decide whether breast cancer patients would benefit from chemotherapy has been identified by a team of scientists...

FDA Ruling On Avastin A 'Critical Test' For Agency, New York Times Editorial Says
The recent "flameout" of the breast cancer drug Avastin "will pose a critical test" on whether FDA will "have the courage to reverse course when a medical treatment that it approved based on preliminary evidence flops badly in follow-up studies," the New York Times says in an editorial...

ABRAXANE(R) Approved For Marketing In Japan For Breast Cancer
Abraxis BioScience, Inc. (NASDAQ:ABII), a fully integrated, global biotechnology company, announced that Taiho Pharmaceutical Co., Ltd. has received approval from the Ministry of Health, Labor and Welfare to market ABRAXANE® IV Infusion 100 mg, Paclitaxel Injection (Suspension with Albumin), for use in the treatment of breast cancer...

Study Finds That The GRB7 Gene Drives An Aggressive Form Of Breast Cancer
Oregon Health & Science University Knight Cancer Institute researchers found that the GRB7 gene drives an aggressive form of breast cancer and acts independently of the HER-2 gene, known to be a stimulator of breast cancer growth. Isolating the role of this gene could ultimately help fine-tune a patient's treatment and enable physicians to provide a more accurate prognosis...

Harder-To-Treat 'Triple Negative' Breast Cancer More Common In African, African-Americans
A new study finds that African ancestry is linked to triple-negative breast cancer, a more aggressive type of cancer that has fewer treatment options. Researchers at the University of Michigan Comprehensive Cancer Center found that, among women with breast cancer, 82 percent of African women were triple negative, 26 percent of African-Americans were and 16 percent of white Americans were...

Study Links African Ancestry To High-Risk Breast Cancer
A new study finds that African ancestry is linked to triple-negative breast cancer, a more aggressive type of cancer that has fewer treatment options. Researchers at the University of Michigan Comprehensive Cancer Center found that, among women with breast cancer, 82 percent of African women were triple negative, 26 percent of African-Americans were and 16 percent of white Americans were...

Merrimack Pharmaceuticals And Sanofi-aventis Initiate Enrollment In A Phase 2 Combination Study Of MM-121 And Exemestane In Breast Cancer
Merrimack Pharmaceuticals, Inc. and sanofi-aventis announced that the first patient has received an initial dose in a Phase 2 randomized double blind clinical study combining MM-121 with exemestane (Aromasin®) in breast cancer patients. MM-121, Merrimack's lead oncology therapeutic candidate, is an antibody designed to block signaling of ErbB3...